The resulting increase in the availability of peripheral irisin improved the cognitive performance of mice in two transgenic models of Alzheimer’s disease (APP/PS1 and 5xFAD), which was also accompanied with reduced glia activation (Islam et al., 2021). This evidence concerns the gene FNDC5 and early-onset autosomal dominant Alzheimer disease.